Abstract:Background: Although there is a significant correlation between obesity and cardiometabolic risk factors, it remains unclear whether these associations indicate causal relationships in either direction. This study aims to investigate the potential temporal relationship between obesity and markers of cardiometabolic risk. Methods: A two-sample bidirectional Mendelian randomization (MR) analysis was conducted using the inverse-variance weighted method and other supplementary MR approaches. These approaches were based on a summary of genome-wide association studies, with the aim of evaluating the temporal relationship between obesity and cardiometabolic risk markers, including glucose, systolic blood pressure (SBP), diastolic blood pressure (DBP), triglyceride (TG), and high-density lipoprotein cholesterol (HDL-C). Additionally, a cross-lagged panel analysis was conducted in the China Health and Retirement Longitudinal Study cohort (n = 3890), measuring body mass index (BMI), fasting plasma glucose (FPG), SBP, DBP, TG, and HDL-C twice at two-time points. Findings: The results of the MR analysis indicated a potential causal association between BMI and increased levels of glucose (b =0.148, 95%CI: 0.128–0.168, P<0.001), SBP (b =0.138, 95%CI: 0.115–0.161, P<0.001), DBP (b =0.221, 95%CI: 0.197–0.245, P<0.001), and TG (b =0.225, 95%CI: 0.193–0.258, P<0.001), along with a decreased risk of HDL-C (b=-0.294, 95%CI: -0.332 – -0.257, P<0.001). Conversely, in the reverse direction, the results suggested a negative correlation between HDL-C and BMI (b =-0.029, 95%CI: -0.043 – -0.014, P<0.001), whilst no significant causal effects of other cardiometabolic risk markers on BMI were identified (all P>0.05). Sensitivity analyses confirmed the robustness of these findings. The outcomes of the cross-lagged panel analysis aligned with the MR results. After adjusting for potential confounders, the panel coefficients (b1) from baseline BMI to follow-up FPG, SBP, DBP, and TG were significantly greater than the panel coefficients (b2) from baseline FPG, SBP, DBP, and TG to follow-up BMI (b1=0.098 versus b2=0.001, Pdifference<0.001 for FPG; b1=0.092 versus b2=0.014, Pdifference<0.05 for SBP; b1=0.079 versus b2=0.030, Pdifference<0.05 for DBP; b1=0.130 versus b2=0.041. Pdifference<0.001 for TG). Additionally, there was no significant difference between the panel coefficient from baseline BMI to follow-up HDL-C and the panel coefficient from baseline HDL-C to follow-up BMI (b1=-0.075 versus b2=-0.049, Pdifference=0.250). Interpretation: Our findings indicate a potential unidirectional causal association from BMI to glucose, blood pressure, and TG. Furthermore, a bidirectional relationship was observed between BMI and HDL-C. Funding: This study was partly funded by National Key Research and Development Program of China (2017YFC0907004). We sincerely thank the compilers of the GWAS summary dataset and the participants and investigators of CHARLS for data collection and management of data resources. We also would like to thank the grants from National Key Research and Development Program of China (2017YFC0907004).Declaration of Interest: The authors declare that they have no competing interests.

Temporal Relationship Between Insulin Resistance and Lipid Accumulation After Bariatric Surgery: a Multicenter Cohort Study

Independent Association of Liver Fat Accumulation with Insulin Resistance

Lipid Accumulation Product Predicts Diabetes Remission After Bariatric Surgery in Chinese Patients with BMI < 35 kg/m2: a Multicenter Cohort Study

Abstract P181: Temporal Relationship Between Changes in Body Weight and Insulin Resistance and Its Impact on Blood Pressure in Response to 2-year Weight-loss Diet Interventions: the POUNDS Lost Trial

Evaluation of Insulin Resistance Improvement after Laparoscopic Sleeve Gastrectomy or Gastric Bypass Surgery with HOMA-IR.

Body Adiposity Index Is Predictive Of Weight Loss After Roux-En-Y Gastric Bypass

A Multi-Center Study on Glucometabolic Response to Bariatric Surgery for Different Subtypes of Obesity

Serum Stearic Acid/palmitic Acid Ratio As a Potential Predictor of Diabetes Remission after Roux‐en‐Y Gastric Bypass in Obesity

Temporal Relationship Between Obesity and Cardiometabolic Risk Markers: an Integrated Two-Sample Bidirectional Mendelian Randomization Study and Cross-Lagged Panel Analysis

Reducing the 10-year risk of ischemic cardiovascular disease to receive early cardiovascular benefits from bariatric surgery for obesity in China

Acute Changes in Non-esterified Fatty Acids in Patients with Type 2 Diabetes Receiving Bariatric Surgery

The Correlation Between Visceral Fat Area to Skeletal Muscle Mass Ratio and Multiorgan Insulin Resistance in Chinese Population With Obesity

Association of the apolipoprotein B/apolipoprotein A-I ratio and low-density lipoprotein cholesterol with insulin resistance in a Chinese population with abdominal obesity

Clinical study of insulin resistance for patients during elective abdominal surgery

The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations : distinct metabolic effects of two fat compartments.

Clinical Observation of Insulin Resistance During Selective Abdominal Surgery

Longitudinal changes of serum metabolomic profile after laparoscopic sleeve gastrectomy in obesity

Short-Term Dynamics and Metabolic Impact of Abdominal Fat Depots After Bariatric Surgery

Clinical Study of Insulin Resistance for Patients after Selective Abdominal Surgery

Correlation analysis of dynamic changes of abdominal fat during rapid weight loss after bariatric surgery: A prospective magnetic resonance imaging study

Association of Visceral Obesity Indices With Incident Diabetic Retinopathy in Patients With Diabetes: Prospective Cohort Study